Parameters effecting on photocatalytic degradation of the phenol from aqueous









    	   






   














 '*+ ,-.*/0 ''1'
23(
45/678 945:;&<0 &5= >?@ 4A B(C:B7/
'BD+ D/5E 45:;&FG':'(/8 CH:I3J D'565K*C.0 ,*C55L:/2M2<BNKG4BO 'BD
C*C5P:"Q.IR45K&*0 M= 3
C45:;&FGC*J RD4C:2;D*<
 	+ DS *C:50 <T*C:CU*,V :W*''





^5&M:<A _ *J RD4C:`	:CZ2;D&1A '*"B*2;D<CBD
A '
*CI'` 





C45:;&(N+ D/d2YP<\*0 M= 3
C55L:'945K&e*25&*45%:C65K9B*45%:CB65K
4525&9:$C2&/'C&5UJ C:CYP>\I*C:$C2(/CU45*D9f B*J RBDA (C:45(g
(N+ D/I'*:= 3
9I'*IR9I'B**C.'_ 94K*C/h 5H0 &'B
,CV BI5&B/Ca/'BbB(N+ B,
YP<\< 
  0 ;UI:"45K&BB*0 BM= 3
C55L:'C45:;&(N+ D/f *J RD4C:2;D
IR
Q.<











F %C&C:)  G-B/,HIJ	F %&










F 3:%VW #:(%@R(K!LMX %4=5%
C@	)	&S 	:) %B4)	P%NC-@/
T!YYZ:6<(4=5%:I.:C-	C[







 CX C%_` C	C($	5C:C
-
E\ C @T	











,R6:)	,4,,b 26$	 3$` 
 C%:E64$	5: ,3,c%-2,F 3














C	-F @C)n C6,36C4%C-:C6=@ C@
/,/,-E+4=5%	CC,TCKML
/C-@ C(,^C3,K!YYlM4=5C%F %C&










:C C,3,; <C	C24=5%(G,F @)
	,mI/4$	5KdML:CB	J	-c,
4%:C-2,5CF C]6,36CC@ $G&:)
























/	v + )C:C^C%,:) &
	 $G&,N^-: 7Lo C+
)" F @t+e @>p	!l=K4 ,CH
0Z*6,6/dw9Ywl.	C
)M/C
mIK6C/C	; <*YMKfMD 	Ck :C
Cb ]6:
[LF @tC+uC<C@G,
 e x ,^,y C<C-:3C=6C
















































































D ,:97 _:6=@	@D (%- &.H
 V.D ,4%/PG0lCG 
<Nc,4%-:5
B4%:-@	,N C%,N:@






0.16 ng/mlMD CCCW` %CCCpc(CCC/
KPIntra=%7.7MC=6CC%|" LC4$	5C





KSensitivity=1mU/MD CW` %Cp c(C/
KPIntra=%6.5MCC%|" C.CL)	C
.































 4$	5 .   4$	5 :,3, ; <
.  % T	,&  =6  %6 )	
.
K!YLM
HOMA-IR = [(mg/dl) %6)	
. × (mU/L)4$	5





 2  : ^
_  :%c 	R(, :
& /2 + 	
  6=6  
&"FOOD PROCESSOR 2"' () S 	
c 6&% $) ^
_ :[	, L/	 g)
	@KVO2maxMr%[  /	,N 46&D 	P)
:_,K!ML /s(H=6H=6
 T6c%/%	)<(+.





6&.   -) S _, :?3 L.  
=6)H:?34%	?H@4 $S _,
  4 $ S _, 	 6, F  :?3 4%
6&..L/IkP$)=6T,
SAEHAN-SH 5020 /65
















@.D -4 ,D =:%+$CN/	C,N














D C-D C=Co C%	)$CN/	C,N=6




; <CCCF @CCC)VO2maxP=F %CCC&
:6(G,KTBLM
D C-D C=Co %	)$N/	,Nc



























( )*+,- $&.- /0'12- / 3 $. 4 	 %.# .5  $
 	
 P 	 
  
   




 !" #!$ %!"$%!&$ '!((!#( )*+
$$"!$*
,!"(!%- #!"."!#( %!"$$!&%  / 

0	1+
'!$%!$  !.%! . (! $! . )*+
$$"!$*




$"!$$"!$ $'!$&.!$ $'!$& !$ )*+
$$"!$*
$%!$$%!$- $,!$&$!$ $'!$& !$  / 
 789+: ;< =>

("!$#"!$ (! &! ' &! "! ' )*+
$$"!$*
#!"''!.- (!.(! " ,!.'! ,  / 
 ? @A2 
"!%.!$- '! (!   .!  ! . )*+
$$"!$*
&!"'!% ,! %! # ,! (! .  / 
VO2max!! 








  ! 
 c :) 	 4% p F @t+ 
k  :6&%9
6=@ 4=5% /, F @) n  	@ 4%- :
4$	5 : ,3, ; <  4$	5   
 )	
.HDLLDL  TG TC(G, 7 
 LF @) n  	@ 4%- 4(U-@(G,
/	; <4 $:-)S _,5 //
(G,F %&/Ik	@/	g)
 L p r3_ :c6  4=5%  :? 
 @ :6&% /-@  ' 	%@K!YY9KMYM -_, 
/-@K!YYKMM/-@	I K!YYfKM!*M
 /-@  $K!YYKMdM	 	5-@ L433_, 4%
c:)/!1lD 	@4%-:6=@
lZ1dZF @) n  ` 
H /p  g) k
	,N   4=5%@.  , LF @) 2N
  / F @) :  4=5%5 / I k
 L 4(U-@/-@  	QK!Y M 7!:6=@
4=5%6,366,3,)D (%-







 a| &  6K*\ L D  ^3, 
( )*6,- $&.-  2%& '7- 	 4 	 %.# .5  $
 	
  P 	 
   





'%!$%%!$- ..!  &!. #! ,$!. )*+
$.,!$* 
(&!%&#!"- ..!".,!%  (!  .!.  / 
visfatin 
ng/ml	 
&!%$&!$ "!''#!( '!'.&!( )*+
(%&!$
(!"("!$- "!%,'!. ,!%',!'  / 
Insulin  
µg/ml	  
,!&'&!$- &!"%,!(, %!(%!(# )*+
$(!$ 
,!".$!( '!#(!(( "!" (!($  / 
glucose  
mg/dl	 
#,!$$%!$- . !" "!% '(!"  !% )*+
#, !$
'"!$$#!$- '"!$%$!" , !$%&!"  / 
HOMA-IR 
,!"''!%- &! #""   ! ."", )*+
%#(!$
,!,.,!% - #!#'" ' .!"" "'&  / 
TG 
(mg/dl)  
,!"%%!"$- "!%""#' .!%""&' )*+
.."!$
"!%%(!% (!% "&% '!%'"#(  / 
TC 
(mg/dl) 
(!"  !- ,!#,! , (!,(! , )*+
%,#!$
%! #%!$ %!''! ' "!.&! .  / 
HDL 
(mg/dl)  
'!"% !(- #!"("", ,!% "%' )*+
#'!$
'!%#,!, %!%,""(  !%(""   / 
LDL 
(mg/dl)  
$% !$*  .'%"'$  #""&'#  (#"#$# )*+  BCA2 8+D +
 %#&"(.- %$%".%% %,'",",  / 1+ 8+ 
.$%!$ %!" ,!"- (!"",!'$ %!". !'% )*+  EFGH 
 (!",'!,- "!,"!.,  !",'!'%  / 0	 
"& !$ '$#!"(  &(!%%# .'%!%$& )*+  A +FGH 
 '. !#- %,'!"&# '.(!"(.  / 0	 
$  !$*  (! $,(!& $!%(%!&# '!%",!#& )*+  ?FGH 
 %#$!",- ,!"#,!'# .!%.,!#   / 0	 






/-@K!YYZ M 4=5% 4 [ :	. q@
 @, % IK!ZM L6  ,
 / I F @) D 33_ :  :  t%




  6% /  /,  ` 
H /p  g)
	@ 4%-  a 
,	@, 2N % (65 
/,:))/	; < T65
) LDL
HDLW 2N r3_  6 )	
.  L:
%Va%#.:))E2NE
7 2N r3_ s%6  	3$ 	[ :  4-,
 :6V.K!dM L-@  ,/K!YYl M/	( 
74=5%:)	-!:<I4%-:6=@
 D   7fZ &x , /t5) g) k
 J	%  mI /-!^-_  & 
` :G[)	
.lYZYF @)k% ,L
%#	$	%&^,	 W 2NK / I k
HDL M@ 	,N   &x , /t5) g) 
) " .K!fM L /-@  $K!YYMF @)  
4$	5:,3,-E+4=5%j	?(G,
e x ,  mI/*YY0YY$)	
)
 T	[  4%- :5
B @  #!4%- :6=@
	-/	(	@KdML@^3,:c6	
 p r3_ /-@  (,K!YYl MF %&
o +-E+4=5%dD 	@4%-,
fY/-  $&  ` 
H /p g) k
	- @, )	
. ^-_ TE6< L^$ 2N





@ %^,	  ^365, h/ /	I; < 
/	K!ZML/(I	; ],4%F +








X %_  :65	 (%- 	 4% :) ) /	(





	K* M %(:)  :6V. ( :p& 4%
% /	( : /	  ,  4=5%&c  X
>?:)& ,R6&.R%I
4=5%4 $:-)S _,5:6h
 LF @) n  6,36 4%- p r3_ 
(G,4 $:-)S _,5%/,:)
  4=5% (G, F @) ^%|  L@(I4
/# / 4 (G,  g, h D G$?, <
 /N %-E+ j	?  I &  4=5%
 / 	 ; <  /K!Z !9 LMr3_ 




 7  4$	5  )	
.	2 , %
F @)-@4$	5:,3,/,(G,





 D 33_	.+K!YYdKM* M4U	, K!YYfKM0 M@
6 	/-@ $s%K!YYMKd M		5-@L
 % /-@  $K!YYM :)  / !:6=@
  , 4=5% (G, F @) n  	@ 4%-
mI/4$	5:,3,; <	2	 ,
Kd LM /-@  @	)	&K!YYZ M:) ) /	(

 ($	5 : 
- a T-6 4=5%
:6 4$	5 (() ' 5 /	( : 3 4=5%
:,3,),	X %4-,:I. 
 4$	5K* LM	$	% :6 4% % K!YYf M
: k< 4=5% :) ) " . 	< :G$?,
($	5KZML
h D G$?, <>? 4 (G,
 @, P$ i-   4=5% L:
-B 
 /-@  {  :G$?,K!YYd M' 	G, h 




 LDL-365, h %5
.  4%+ /, 
	BK*LMpr3_F @)a
>?































































:(&x ,M4$	5C:C,3,; <	 ,


























4% : :B	 j[ : h	, m	& :G$?, :)
 H - : 33_d!9T  :)   ,
*9Y   4% %. c  
@t+G,	<%3` ,:

,%-[<:  j[  $
% ,E	)V,@:
)4(I::)




1. Cummings DE, Schwartz MW. Genetics and pathophysiology of human obesity. AnnuRev Med.2003; 54: 
453–71. 
2. Nicklas B, Berman DM. Endurance exercise and adipose tissue. CRC Series in Exercise Physiology.2002; 
54: 79-88. 
3. Fukuhara A, Matsuda M, Nishizawa M,Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, 
Ichisaka T, Murakami H,et al. Visfatin: a protein secreted by visceral fat that mimics the effects of  insulin. 
Science. 2005; 307(5708): 426-30. 
4. Beqtowski J. Apelin and visfatin: Unique beneficial adipokines upregulated in obesity? Med Sci Monit. 
2006; 12(6): 112-9. 
5. Fonseca-Alaniz MH, Takada J, Alonso-Vale MI, Lima FB. Adipose tissue as an endocrine organ: from 
theory to practice.  J Pediatr. 2007; 83: 192-203. 
6. Antuna-Puente B, Feve B, Fellahi S, Bastard JP. Adipokines: the missing link between insulin resistance and 
obesity.  Diabetes Metab. 2008; 34(1): 2-11. 
7. Foroughi M, Hosseinzadeh M, Zahediasl S, Hoseinpanah F, Momenan A, Eshraghiyan M et al . Serum 
Visfatin Concentration in Patients with Metabolic Syndrome. Iranian Journal of Endocrinology and 
Metabolism. 2010; 11 (2) :151-7 [Persian]. 
8. Sun G, Bishop J, Khalili S, Vasdev S, Gill V, Pace D, Fitzpatrick D, Randell E, Xie YG, Zhang H. Serum 
visfatin concentrations are positively correlated with serum triacylglycerols and down-regulated by 





9. Mohebbi H, Moghaddasi M, Rahmaninia F, Hassannia S, Novrozi H. Effect of 12 weeks of aerobic exercise 
on plasma adiponectin, insulin resistance , and peripheral fat volume in obese middle-aged men. .2010; 
51(3): 33-46. [Persian]. 
10. Haus JM, Solomon TP, Marchetti CM, O'Leary VB, Brooks LM, Gonzalez F, Kirwan JP. Decreased visfatin 
after exercise training correlates with improved glucose tolerance. Med Sci Sports Exerc. 2009; 41(6): 1255-
60. 
11. Mohammadi Damieh A, Khajelandi A, Rostami A, Asadi E. The Effects of eight weeks of resistance versus 
endurance training on plasma visfatin level in middle-aged men. Journal of armaghan danesh. 2009 ; 15(3): 
233-42. [Persian]. 
12. MckenzieJA. The influence of visfatin and visfatin gene polymorphisms on glucose and obesity-related 
variables and their responses to aerobic exercise training. Kinesiology. 2010; 303: 314-28. 
13. Pagano C, Pilon C, Olivieri M, Mason P, Fabris R, Serra R, Milan G, Rossato M, Federspil G, Vettor 
R.Reduceplasma visfatin/pre B-cell colony enhancing factor in obesity is notrelated to insulin resistance in 
humans. J Clin Endocrinol  Metab. 2006; 91(8): 3165-70. 
14. Moschen AR, Kaser A, Enrich B, Mosheimer BTheurl M, Niederegger H, Tilg H. Visfatin, an 
adipocytokine with proinflammatory and immunomodulating properties.  J Immunol. 2007; 178(3): 1748- 
58.  
15. Revollo JR, Korner A, Mills KF, Satoh AWang T, Garten A, Dasgupta B, Sasaki Y, Wolberger C, 
Townsend RR, et al. Nampt/PBEF/Visfatin regulates insulin secretion in [beta] cells as a systemic NAD 
biosynthetic enzyme. Cell metab. 2007; 6(5): 363-75. 
16. Lee KJ, Shin YA, Lee KY, Jun TW, Song W. Aerobic exercise training-induced decrease in plasma visfatin 
and insulin resistance in obese female adolescents. Int J Sport Nutr Exerc Metab. 2010; 20(4): 275-81. 
17. Deitel M. Overweight and obesity worldwide now estimated to involve 1.7 billion people. Obes Surg. 2003; 
13(3): 329-30. 
18. Soheyli S, Gaeeni A, Nikbakht H, Sori R, Parsiyan H. Effects of endurance training on inflammatory 
markers to predict heart disease –coronery. Sporting Life Sciences. 2008 ; 2: 93-110. [Persian]. 
19. Freidewald WT, Levy RI, Fredrikson DS. Estimation of the concentration of LDLc in plasma, without use of 
the preparative ultracentrifuge. Clin Chem. 1972; 18(6): 499-502. 
20. Cummings DM, Henes S, Kolasa KM, Olsson J, Collier D. Insulin resistance status: Predicting weight 
response in overweight children. Arch Pediatr Adolesc Med. 2008; 162(8): 764-8. 
21. Mackenzie B. 101 Performance evaluation tests. 2005; 33 -4. 
22. Williams MH. Nutrition for health, fitness and sport. MC craw Hill, 6th Edition, 2010; 466-7. 
23. Choi K, Kim J, Cho G, Baik S, Park H, Kim S. Effect of exercise training on plasma visfatin and eotaxin 
levels. Eur J Endocrinol. 2007; 157(4): 437-42. 
24. Seo D, So WY, Ha S, Yoo EJ, Kim D, Singh H, Fahs CHA, Rossow L, Bemben DA, Bemben MG, et al. 
Effects of 12 weeks of combined exercise  training on visfatin and metabolicsyndrome factors in obese 
middle-aged women. Journal of Sports Science and Medicine. 2011; 10: 222-226. 
25. Berndt J, Kloting N, Kralisch S, Kovacs P, Fasshauer M, Schon MR,  Stumvoll M, Blüher M. Plasma 
visfatinconcentrations and fat depot-specific mRNA expression in humans. Diabetes. 2005; 54(10): 2911–6. 
26. Haider DG, Pleiner J, Francesconi M, Wiesinger GF, Muller M, Wolzt M. Exercise training lowers plasma 
visfatin concentrations in patients with type 1 diabetes. J Clin Endocrinol Metab. 2006; 91(11): 4702-4. 
27. Brema I, Hatunic M, Finucane F, Burns N, Nolan JJ, Haider D, Wolzt M, Ludvik B. Plasma visfatin is 
reduced after aerobic exercise in early onset type 2 diabetes mellitus. Diabetes Obes Metab. 2008; 10: 600-2. 
28. Ravasi A, Aminiyan T, Gaeeni A, Haghighi A, Hamedinia M. Effects of endurance exercise on pro-
inflammatory cytokines and insulin resistance in obese men. Harkat 2005; 28: 31-49 [Persian]. 
29. Wen Y, Wang HW, Wu J, Lu HL, Hu XF, Cianflone K. Effects of fatty acid regulation on visfatin gene 
expression in adipocytes. Chin Med J. 2006; 119(20): 1701-8. 
30. Wang T, Zhang X, Bheda P, Revollo JR, Imai S, Wolberger C.Structure of Nampt/ PBEF/ Visfatin, a 
mammalian NAD + Biosynthetic enzyme. Nat Struct. 2006; 13(7): 661-2. 
31. De L, Aller R, Conde R, Izaola O. Circulating visfatin in obese non-diabetic patients in relation to 
cardiovascular risk factors, insulin resistance and adipocytokines: A contradictory piece of thepuzzle. 
Nutrition. 2010; 26(11-12): 1130-3. 
32. Ross R, Janssen I, Dawson J, Kungl A, Kuk J, Wong S, Nguyen-Duy TB, Lee S, Kilpatrick K, Hudson R. 
Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obes 
Res. 2004; 12(5): 789–98. 
33. Friedenreich C, Neilson H, Woolcott C, Tiernan A, Wang Q, Ballard-Barbash R, Jones CA, Stanczyk FZ, 
Brant RF, Yasui Y, et al. Changes in insulin resistance indicators, IGFs, and adipokines in a year-long trial 






34. Davidson L, Hudson R, Kilpatrick K, Kuk J, McMillan K, Janiszewski PM, Lee S, Lam M, Ross R.. Effects 
of exercise modality on insulin resistance and functional limitation in older adults. Arch Intern Med. 2009; 
169(20: 122-31. 
35. Bahrami A, Saremi A. Effect of caloric restriction with or without aerobic training on body composition, 
blood lipid profile, insulin resistance, and inflammatory marker in middle-age obese /overweight men. Arak 
University of Medical Sciences Journal. 2011; 14 (3) :11-9 [Persian].                                                                                                                                             
36. Kang J, Robertson RJ, Hagberg JM, Kelley DE, Goss FL, DaSilva SG, Suminski RR, Utter AC.Effect of 
exercise intensity on glucose,and insulin metabolism in obese individuals and obese NIDDM patients. 
Diabetes Care. 1996; 19(4): 341–9 
37. Mayer-Davis EJ, Agostino R, Karter AJ, Haffner SM, Rewers MJ, Saad M Bergman RN. Intensity and 





























Effect of 9 weeks of aerobic training on serum visfatin 
level and insulin resistance index in obese women  
 
Amir Hossein Haghighi  
Associate Professorin Hakim Sabzevari University, Faculty of physical education and sport sciences. 
 
Hadi Yarahmadi  
MSc in exercise physiology, Hakim Sabzevari University, Faculty of physical education and sport sciences. 
General courses, Faculty of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran   
 
Malileh Shojaei.  
MSc in exercise physiology, Hakim Sabzevari University, Faculty of physical education and sport sciences. 

Received:  , Revised:  , Accepted:   
Abstract
Introduction: Visfatin is a newly discovered adipokine which 
increases with obesity. It is not clear whether endurance training 
which induces changes in adipose tissue and blood lipids might 
decrease the plasma level of visfatin as well. The aim of this 
study was to investigate the effect of 9 weeks of aerobic training 
on serum visfatin level and insulin resistance index in obese 
women.
  
Materials and methods: Method of research was 
semiexperimental. Twenty-eight obese female volunteered and 
were randomly divided into experimental (14 subjects with means 




(14 subjects with means of weight 79.9 ± 9.5 kg, and BMI 34 ± 
3.9 kg/m2) groups. Aerobic training protocol consisted of 4 
sessions per week for 9 weeks.
 
Each training session was a slow 
running trial at intensity of 65 to 75 percent of maximal heart rate 
for a period of 15 minutes. To follow the principle of overload, 
half-a-minute was added to each session after the second week, 
so that, at the last session the running time reached to 31 
minutes. Before and after the training period, blood sampling was 
performed. Data were analyzed using independent t test and 
ANCOVA. 
Results: Results showed significant reduction of serum visfatin 
level (p < 0.05), and no significant difference in insulin resistance 
index, serum HDL, LDL, TC and TG between the control and 
experimental groups (p > 0.05). In addition, aerobic training 
reduced significantly body mass index, body weight, waist to hip 
ratio, body fat percent, and increased significantly maximum 
oxygen uptake (p < 0.05). 
Conclusion: It can be said that 9 weeks of aerobic training can 
cause significant reduction of serum visfatin and no significant 
change in insulin resistance index in obese
 
women.  
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